Italy· 029533027
ATENOLOLO PENSA
A atenolol product containing atenololo, registered in Italy by TOWA PHARMACEUTICAL S.P.A., on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Atenolol is registered in 17 of 19 countries.
Countries holding a registration under ATC C07AB03 (atenolol), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 9 of them publish a price we can compare per daily dose
Atenolol · ATC C07AB03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atenolol costs, country by country.
Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.11 in Italy to $0.58 in Switzerland — a ×5.2 gap.
- Italy: $0.11 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Atenolol · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.58
- FR France$0.12
- IT Italy$0.11
The record
At a glance
AIFA (Italy)- Active substance
- Atenololo
- Manufacturer
- TOWA PHARMACEUTICAL S.P.A.
- Country
- Italy (IT)
- ATC code
- C07AB03
- ATC class
- Atenolol
- Defined daily dose
- 75 mg, O
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic029533027"100 MG COMPRESSE" 42 COMPRESSEEUR 5.53
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for atenolol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atenolol · interactions on record
428 records
- 11 severe
- 181 moderate
- 20 minor
- 174 info
Most severe, free to view
- DolasetronA04AA04severe
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
42 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C07AB03
Atenolol, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9796da2f-441c-42ca-a140-1a73792b3f86 GET /v1/drugs/9796da2f-441c-42ca-a140-1a73792b3f86?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"100 MG COMPRESSE\" 42 COMPRESSE",
"source": "aifa",
"currency": "EUR",
"substance": "Atenololo",
"reference_pack": "42 UNITA' 100 MG - USO ORALE",
"public_price_eur": 5.53,
"ssn_reference_price_eur": 5.53
}See everything about atenolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.